Chen, P.-H.; Ho, C.-L.; Lin, C.; Wu, Y.-Y.; Huang, T.-C.; Tu, Y.-K.; Lee, C.-H.
Treatment Outcomes of Novel Targeted Agents in Relapse/Refractory Chronic Lymphocytic Leukemia: A Systematic Review and Network Meta-Analysis. J. Clin. Med. 2019, 8, 737.
https://doi.org/10.3390/jcm8050737
AMA Style
Chen P-H, Ho C-L, Lin C, Wu Y-Y, Huang T-C, Tu Y-K, Lee C-H.
Treatment Outcomes of Novel Targeted Agents in Relapse/Refractory Chronic Lymphocytic Leukemia: A Systematic Review and Network Meta-Analysis. Journal of Clinical Medicine. 2019; 8(5):737.
https://doi.org/10.3390/jcm8050737
Chicago/Turabian Style
Chen, Po-Huang, Ching-Liang Ho, Chin Lin, Yi-Ying Wu, Tzu-Chuan Huang, Yu-Kang Tu, and Cho-Hao Lee.
2019. "Treatment Outcomes of Novel Targeted Agents in Relapse/Refractory Chronic Lymphocytic Leukemia: A Systematic Review and Network Meta-Analysis" Journal of Clinical Medicine 8, no. 5: 737.
https://doi.org/10.3390/jcm8050737
APA Style
Chen, P.-H., Ho, C.-L., Lin, C., Wu, Y.-Y., Huang, T.-C., Tu, Y.-K., & Lee, C.-H.
(2019). Treatment Outcomes of Novel Targeted Agents in Relapse/Refractory Chronic Lymphocytic Leukemia: A Systematic Review and Network Meta-Analysis. Journal of Clinical Medicine, 8(5), 737.
https://doi.org/10.3390/jcm8050737